ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and ...
Driven by the new strategy, ResMed expects to help more than 500 million people worldwide achieve their full health potential in 2030.
ResMed Inc. (RMD) Latest Stock News & Headlines - Yahoo …
Get the latest ResMed Inc. (RMD) stock news and headlines to help you in your trading and investing decisions.
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's ...
5 days ago · Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.
ResMed Adopts New Operating Model to Accelerate Long-term …
SAN DIEGO, November 9, 2023 – ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team.
UPDATE -- ResMed Unveils New Collection of Digital and …
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced new patient-centric products designed to enhance the therapy journey for sleep apnea patients.
UPDATE -- ResMed Unveils New Collection of Digital and …
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today...
News | Resmed Inc
Sep 10, 2024 · news@resmed.com 1.858.289.7272. Investor Contact. investorrelations@resmed.com 1.858.836.5000. Newsroom Alerts. To opt-in for email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to …
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and ...
Sep 30, 2024 · NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder returns at an Investor Day...
ResMed Unveils 2030 Strategy to Drive Growth ... - Morningstar
Sep 30, 2024 · NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder returns at an Investor Day...
ResMed targets resupply, rePAP for growth | HME News
Oct 25, 2024 · SAN DIEGO – ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, performance and patient eligibility in real-time, available to all HME providers, not just those using Brightree.
- Some results have been removed